Occidental Petroleum heads into its Q1 2026 earnings report as the clear laggard in its peer group, with the stock pricing in a deteriorating macro backdrop while analysts and fundamentals point materially higher.
The price action tells the starkest part of the story. OXY fell 7.1% on Wednesday alone, extending a one-month slide to 12.5%, closing at $55.12. That compares poorly to close peers: OVV gained 7.9% over the same week, APA rose 7.3%, and CHRD added 6.4%. Even COP and EOG — themselves under pressure — managed to limit weekly losses to under 1%. OXY's underperformance is notable in a group that has broadly stabilised. Options positioning is slightly more defensive than usual, with the put/call ratio at 0.49, just above its 20-day mean of 0.47. That's not an extreme reading. The borrow market adds little drama: cost to borrow is a negligible 0.54%, short interest is only 2.7% of free float, and availability is wide open. Short sellers are not pressing the bet here.
The debate is squarely between valuation and the oil price. Bulls point to a company trading at roughly 14.4x trailing earnings with a mean analyst target of $64.58 — about 17% above the current price — and a dividend score ranked in the 99th percentile. EPS momentum scores are also strong: 97th percentile on 90-day EPS momentum and 97th on EPS surprise history, meaning the company has repeatedly beaten estimates and analysts have been revising up. Wells Fargo holds an Overweight with a $72 target. Recent analyst activity has been constructively directional — multiple firms raised targets in April, with Scotiabank lifting to $57 and UBS to $67, while JPMorgan upgraded from Underweight to Neutral in March. Sixteen of 21 analysts are at Hold, however, suggesting the Street sees a ceiling on near-term upside. The bear case is simpler: the stock's EV/EBITDA has compressed by 0.6 turns over the past 30 days, the forward EPS growth metric ranks in only the 18th percentile, and oil price weakness directly pressures the model. Net debt of roughly $10.5 billion leaves the balance sheet sensitive to commodity moves.
One structural backstop worth noting is Berkshire Hathaway's 26.7% stake — unchanged through Q4 2025 — which anchors the shareholder base and limits aggressive short positioning. The ORTEX short score of 31.3 is modest. This is not a heavily contested name in the lending market; the short thesis is macro, not company-specific.
Today's print is therefore a test of whether OXY's operational execution and cash generation can hold the earnings multiple steady against an oil-price backdrop that has already done visible damage to the stock.
See the live data behind this article on ORTEX.
Open OXY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
